Elutia's Upcoming Investor Conference Appearances
Elutia Inc. (Nasdaq: ELUT), known for its revolutionary work in drug-eluting biomatrix technologies, is excited to announce that key executives will represent the company at several upcoming investor conferences. This is an excellent opportunity for Elutia to connect with institutional investors, showcasing its vision and ongoing projects.
LD Micro 15th Annual Invitational
One of the highlighted events is the LD Micro 15th Annual Invitational taking place in New York. This prestigious conference presents an opportunity for Dr. Randy Mills, the President and Chief Executive Officer, along with Matt Ferguson, the Chief Financial Officer, to engage with investors in a format that includes both presentations and one-on-one meetings.
Details of the Event
The LD Micro conference is scheduled for a presentation on Thursday at 12:30 p.m. ET (9:30 a.m. PT). Attendees can expect valuable insights into Elutia's strategies and future growth plans. A webcast will be available for those who wish to tune in virtually.
Planet Microcap Showcase
Following the LD Micro event, Elutia will actively participate in the Planet Microcap Showcase in Las Vegas. This setting is another platform where executives will share their insights and engage with both potential and current investors through various meetings.
About the Showcase
The Planet Microcap Showcase is particularly important as it allows for intimate interactions between company representatives and investors. Elutia's presentation is set for Wednesday at 4:00 p.m. ET (1:00 p.m. PT). This event will also use a webcast to reach a broader audience.
Engaging with Investors
Elutia is dedicated to fostering relationships with its investors. Management has made arrangements for one-on-one meetings with interested institutional investors during both conferences. If you are an investor looking to set up a meeting, reaching out to representatives from LD Micro or Planet Microcap is encouraged, or you can easily communicate with Elutia's investor relations team.
How to Connect
For those interested in scheduling a personal meeting, please reach out via email to their investor relations team. They are eager to provide insights into the company’s performance and strategic direction.
Understanding Elutia's Mission
At the core of Elutia's operations is a commitment to developing and bringing to market innovative drug-eluting biomatrix products. These advancements are crucial in enhancing the compatibility of medical devices for patients, ensuring better outcomes and improved quality of life.
The Vision of Elutia
Elutia's overarching mission is to humanize medicine. The company aims to meet the growing needs of patients requiring implantable technology with products that strive for excellence without compromise. As they continue to grow, their focus remains firmly on patient-centric solutions.
Meet the Investor Relations Team
For investor inquiries, Matt Steinberg from FINN Partners is available to provide assistance. His experience and knowledge will be beneficial for anyone looking to understand more about Elutia's innovation and market strategy.
Contact Information
If you have any questions or need further information, Matt Steinberg can be reached directly via email. Engaging with Elutia's investor relations team can provide detailed insights about the upcoming conferences and the company's future prospects.
Frequently Asked Questions
What is the significance of the LD Micro Invitational for Elutia?
The LD Micro Invitational provides Elutia a platform to connect with investors directly, showcasing its growth strategies and innovations in the biomatrix technology sector.
When is Elutia's presentation at the Planet Microcap Showcase?
Elutia's presentation at the Planet Microcap Showcase is scheduled for Wednesday at 4:00 p.m. ET.
How can investors schedule a meeting with Elutia's management?
Investors can schedule meetings by contacting representatives from LD Micro or Planet Microcap, or directly through Elutia's investor relations email.
What is Elutia's focus in the medical technology industry?
Elutia focuses on developing drug-eluting biomatrix products to enhance the compatibility of medical devices, ultimately aiming to improve patient outcomes.
Who should I contact for investor relations at Elutia?
Matt Steinberg from FINN Partners is available for investor inquiries, providing insights and assistance regarding Elutia's developments.
